Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK1 | Q13153 | 15/20 | 0.80 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | TERT | O14746 | 3/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8530470 | 0.78 | PAK1 (0.72) | PAK1MAPK1TERT | |
| SCHEMBL8527905 | 0.77 | PAK1 (0.79) | PAK1MAPK1FLT3TERT | |
| Hydrochloric Acid SCHEMBL7554275 | 0.77 | PAK1 (0.77) | PAK1MAPK1FLT3 | |
| SCHEMBL8585959 | 0.76 | PAK1 (0.70) | PAK1MAPK1FLT3 | |
| SCHEMBL8585967 | 0.76 | PAK1 (0.70) | PAK1MAPK1FLT3 | |
| SCHEMBL8415627 | 0.75 | PAK1 (1.00) | PAK1MAPK1FLT3 | |
| SCHEMBL8415630 | 0.75 | PAK1 (1.00) | PAK1MAPK1FLT3 | |
| SCHEMBL32682829 | 0.73 | PAK1 (0.66) | PAK1MAPK1TERT | |
| SCHEMBL28501759 | 0.73 | PAK1 (0.70) | PAK1MAPK1FLT3TERT | |
| SCHEMBL8808140 | 0.70 | PAK1 (0.82) | PAK1MAPK1FLT3TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | claimed |
| WO-2025003545-A1 | DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE WITH ANTI-INFLAMMATORY ACTIVITY | UNIVERSITAT DE VALÈNCIA (ES) | 2025-01-02 | — | — | WO | claimed |
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | UNIV DE VELENCIA (ES) | 2026-03-12 | — | — | US | disclosed |
| WO-2025003545-A1 | DERIVATIVES OF IMIDAZO[1,2-A]PYRIDINE WITH ANTI-INFLAMMATORY ACTIVITY | UNIVERSITAT DE VALÈNCIA (ES) | 2025-01-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070905-A1 | Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity | IL1A, IL6, IL1B | PAK1 4173/4885MAPK1 884/4885FLT3 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.